Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1995 April; 71(4): 894–897.
PMCID: PMC2033741

Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit.


The relationship between negative cervical cytology reports and risk of adenocarcinoma of the cervix was evaluated in a case-control study of 113 cases and 452 controls. All cases and controls had received at least two negative cytology reports. There was no significant difference between the cases and controls in the number of negative cytology reports or in history of cervical abnormality; while a test for trend in the time since last negative cytology report was significant (P < 0.001), the estimated benefit was very modest. Although the estimates of relative protection were higher in women aged less than 35 years than in women aged 35-69 years, this difference was not statistically significant. These results suggest that cervical screening as practised in the 1970s and 1980s was much less effective in preventing adenocarcinoma than squamous carcinoma of the cervix.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (736K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Anderson MC, Fraser AC. Adenocarcinoma of the uterine cervix a clinical and pathological appraisal. Br J Obstet Gynaecol. 1976 Apr;83(4):320–325. [PubMed]
  • Bowman JA, Redman S, Dickinson JA, Gibberd R, Sanson-Fisher RW. The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research. Health Serv Res. 1991 Apr;26(1):97–107. [PMC free article] [PubMed]
  • Boyce JG, Fruchter RG, Romanzi L, Sillman FH, Maiman M. The fallacy of the screening interval for cervical smears. Obstet Gynecol. 1990 Oct;76(4):627–632. [PubMed]
  • Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA, Stolley PD, Fraumeni JF., Jr Epidemiology of cervical cancer by cell type. Cancer Res. 1987 Mar 15;47(6):1706–1711. [PubMed]
  • Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. Duration of relative protection of screening for cervical cancer. Prev Med. 1989 Jul;18(4):411–422. [PubMed]
  • Chilvers C, Mant D, Pike MC. Cervical adenocarcinoma and oral contraceptives. Br Med J (Clin Res Ed) 1987 Dec 5;295(6611):1446–1447. [PMC free article] [PubMed]
  • Cohen MM. Using administrative data for case-control studies: the case of the Papanicolaou smear. Ann Epidemiol. 1993 Jan;3(1):93–98. [PubMed]
  • Dallenbach-Hellweg G. On the origin and histological structure of adenocarcinoma of the endocervix in women under 50 years of age. Pathol Res Pract. 1984 Sep;179(1):38–50. [PubMed]
  • Hurt WG, Silverberg SG, Frable WJ, Belgrad R, Crooks LD. Adenocarcinoma of the cervix: histopathologic and clinical features. Am J Obstet Gynecol. 1977 Oct 1;129(3):304–315. [PubMed]
  • Klassen AC, Celentano DD, Brookmeyer R. Variation in the duration of protection given by screening using the Pap test for cervical cancer. J Clin Epidemiol. 1989;42(10):1003–1011. [PubMed]
  • La Vecchia C, Franceschi S, Decarli A, Fasoli M, Gentile A, Tognoni G. "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet. 1984 Oct 6;2(8406):779–782. [PubMed]
  • Macgregor JE, Moss SM, Parkin DM, Day NE. A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) 1985 May 25;290(6481):1543–1546. [PMC free article] [PubMed]
  • Mitchell H, Medley G. Cytological reporting of cervical abnormalities according to endocervical status. Br J Cancer. 1993 Mar;67(3):585–588. [PMC free article] [PubMed]
  • Olesen F. A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark. Int J Epidemiol. 1988 Sep;17(3):501–508. [PubMed]
  • Parazzini F, La Vecchia C, Negri E, Fasoli M, Cecchetti G. Risk factors for adenocarcinoma of the cervix: a case-control study. Br J Cancer. 1988 Feb;57(2):201–204. [PMC free article] [PubMed]
  • Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst. 1986 Mar;76(3):423–428. [PubMed]
  • Rombaut RP, Charles D, Murphy A. Adenocarcinoma of the cervix. A clinicopathologic study of 47 cases. Cancer. 1966 Jul;19(7):891–900. [PubMed]
  • Sawyer JA, Earp JA, Fletcher RH, Daye FF, Wynn TM. Accuracy of women's self-report of their last Pap smear. Am J Public Health. 1989 Aug;79(8):1036–1037. [PubMed]
  • Schwartz SM, Weiss NS. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol. 1986 Dec;124(6):1045–1047. [PubMed]
  • Shy K, Chu J, Mandelson M, Greer B, Figge D. Papanicolaou smear screening interval and risk of cervical cancer. Obstet Gynecol. 1989 Dec;74(6):838–843. [PubMed]
  • Silcocks PB, Thornton-Jones H, Murphy M. Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data. Br J Cancer. 1987 Mar;55(3):321–325. [PMC free article] [PubMed]
  • van der Graaf Y, Zielhuis GA, Peer PG, Vooijs PG. The effectiveness of cervical screening: a population-based case-control study. J Clin Epidemiol. 1988;41(1):21–26. [PubMed]
  • Walter SD, Clarke EA, Hatcher J, Stitt LW. A comparison of physician and patient reports of Pap smear histories. J Clin Epidemiol. 1988;41(4):401–410. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK